Beijing SL Pharmaceutical Co Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Beijing SL Pharmaceutical Co Ltd with three other
companies in this sector in China:
Boya Bio-pharmaceutical Group Co Ltd
sales of 2.45 billion Chinese Renmimbi [US$348.99 million]
of which 37%
was Blood Products),
Shenzhen Kangtai Biological Products Co Ltd
(2.02 billion Chinese Renmimbi [US$287.00 million]
of which 100%
was Biological products), and
Jinyu Bio-Technology Co Ltd
(1.90 billion Chinese Renmimbi [US$270.02 million]
of which 97%
Beijing SL Pharmaceutical Co Ltd reported sales of 2.17 billion Chinese Renmimbi (US$308.58 million)
December of 2018.
increase of 74.5%
versus 2017, when the company's sales were 1.24 billion Chinese Renmimbi.
Sales of Pharmaceuticals Industry saw an increase
75.2% in 2018, from
1.22 billion Chinese Renmimbi to 2.14 billion Chinese Renmimbi.